Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 1245.00 | 2071.50 | 0.6010 | 0.3594 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 1250.00 | 830.55 | 1782.00 | 2071.50 | 0.8603 | 0.7842 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 1250.00 | 830.55 | 1025.00 | 2071.50 | 0.4948 | 0.1730 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2156.00 | 2071.50 | 1.0408 | 1.0616 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3765.00 | 3914.00 | 0.9619 | 0.9289 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 3767.00 | 3914.00 | 0.9624 | 0.9299 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 2500.00 | 1861.36 | 3946.00 | 3914.00 | 1.0082 | 1.0152 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 3925.00 | 3914.00 | 1.0028 | 1.0052 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 2500.00 | 1861.36 | 3953.00 | 3914.00 | 1.0100 | 1.0186 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 2500.00 | 1861.36 | 1701.00 | 3914.00 | 0.4346 | -0.0806 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 4232.00 | 3914.00 | 1.0812 | 1.1511 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 2500.00 | 1861.36 | 4303.00 | 3914.00 | 1.0994 | 1.1848 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 3963.00 | 3914.00 | 1.0125 | 1.0233 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 2500.00 | 1861.36 | 1679.00 | 3914.00 | 0.4290 | -0.0917 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 2500.00 | 1861.36 | 3259.00 | 3914.00 | 0.8327 | 0.6860 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 3359.00 | 3914.00 | 0.8582 | 0.7342 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 2500.00 | 1861.36 | 1930.00 | 3914.00 | 0.4931 | 0.0343 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 4151.00 | 3914.00 | 1.0606 | 1.1127 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 4220.00 | 3914.00 | 1.0782 | 1.1454 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 2500.00 | 1861.36 | 3032.00 | 3914.00 | 0.7747 | 0.5762 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 1847.00 | 3914.00 | 0.4719 | -0.0072 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 2500.00 | 1861.36 | 4043.00 | 3914.00 | 1.0330 | 1.0614 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4028.00 | 3914.00 | 1.0291 | 1.0543 | |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 2500.00 | 1861.36 | 3712.00 | 3914.00 | 0.9484 | 0.9036 |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 2500.00 | 1861.36 | 3729.00 | 3914.00 | 0.9527 | 0.9117 |